Application 204525
- Type
- ANDA
- Sponsor
- CPDC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FLUDEOXYGLUCOSE F18 | FLUDEOXYGLUCOSE F-18 | INJECTABLE;INTRAVENOUS | 20-300mCi/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 21731-647 | Fludeoxyglucose F 18 | Fludeoxyglucose F 18 | Centre for Probe Development and Commercialization | ANDA | Current |
| 21731-647 | Fludeoxyglucose F 18 | Fludeoxyglucose F 18 | Centre for Probe Development and Commercialization | ANDA | Current |